These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19242112)

  • 41. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein kinase Cδ protects against bile acid apoptosis by suppressing proapoptotic JNK and BIM pathways in human and rat hepatocytes.
    Webster CR; Johnston AN; Anwer MS
    Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(12):G1207-15. PubMed ID: 25359536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.
    Barbacci EG; Pustilnik LR; Rossi AM; Emerson E; Miller PE; Boscoe BP; Cox ED; Iwata KK; Jani JP; Provoncha K; Kath JC; Liu Z; Moyer JD
    Cancer Res; 2003 Aug; 63(15):4450-9. PubMed ID: 12907618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim.
    Lv XB; Zhang X; Deng L; Jiang L; Meng W; Lu Z; Wang X
    Cell Biol Int; 2014 Apr; 38(4):435-43. PubMed ID: 24375836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity.
    Harada H; Quearry B; Ruiz-Vela A; Korsmeyer SJ
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15313-7. PubMed ID: 15486085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells.
    Zhou NN; Tang J; Chen WD; Feng GK; Xie BF; Liu ZC; Yang D; Zhu XF
    Life Sci; 2012 May; 90(19-20):770-5. PubMed ID: 22525372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.
    Tsubaki M; Itoh T; Satou T; Imano M; Komai M; Ogawa N; Mukai J; Nishida S
    Biochem Pharmacol; 2013 Jan; 85(2):163-72. PubMed ID: 23085435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.
    O'Reilly LA; Kruse EA; Puthalakath H; Kelly PN; Kaufmann T; Huang DC; Strasser A
    J Immunol; 2009 Jul; 183(1):261-9. PubMed ID: 19542438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM.
    Tomicic MT; Meise R; Aasland D; Berte N; Kitzinger R; Krämer OH; Kaina B; Christmann M
    Oncotarget; 2015 Oct; 6(32):33755-68. PubMed ID: 26418950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
    Uehara N; Matsuoka Y; Tsubura A
    Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway.
    Thien CB; Dagger SA; Steer JH; Koentgen F; Jansen ES; Scott CL; Langdon WY
    J Biol Chem; 2010 Apr; 285(14):10969-81. PubMed ID: 20133944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of Bim in Photofrin-mediated photodynamically induced apoptosis.
    Wang X; He X; Hu S; Sun A; Lu C
    Cell Physiol Biochem; 2015; 35(4):1527-36. PubMed ID: 25791936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.
    Espina B; Liang M; Russell RG; Hulley PA
    J Cell Physiol; 2008 May; 215(2):488-96. PubMed ID: 18064628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation and down-regulation of Bim by muscarinic cholinergic receptor activation via protein kinase C.
    Styles NA; Zhu W; Li X
    Neurochem Int; 2005 Dec; 47(8):519-27. PubMed ID: 16183168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.
    Arteaga CL; Winnier AR; Poirier MC; Lopez-Larraza DM; Shawver LK; Hurd SD; Stewart SJ
    Cancer Res; 1994 Jul; 54(14):3758-65. PubMed ID: 7913407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells.
    Iglesias-Serret D; de Frias M; Santidrián AF; Coll-Mulet L; Cosialls AM; Barragán M; Domingo A; Gil J; Pons G
    Leukemia; 2007 Feb; 21(2):281-7. PubMed ID: 17151701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bim protein degradation contributes to cisplatin resistance.
    Wang J; Zhou JY; Wu GS
    J Biol Chem; 2011 Jun; 286(25):22384-92. PubMed ID: 21561860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J; Wang W; Wang H; Liu X; Guo X
    Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.